These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8690811)
1. Treating elevated cholesterol levels: the great Satan in perspective. Gibaldi M; Kradjan W J Clin Pharmacol; 1996 Mar; 36(3):189-97. PubMed ID: 8690811 [TBL] [Abstract][Full Text] [Related]
2. [The cholesterol question. Disinformed information]. Bobbio M; Brusca A G Ital Cardiol; 1991 Sep; 21(9):1029-33. PubMed ID: 1790828 [No Abstract] [Full Text] [Related]
4. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention. Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831 [TBL] [Abstract][Full Text] [Related]
5. Systematic review on evidence of the effectiveness of cholesterol-lowering drugs. Gupta A; Guyomard V; Zaman MJ; Rehman HU; Myint PK Adv Ther; 2010 Jun; 27(6):348-64. PubMed ID: 20533012 [TBL] [Abstract][Full Text] [Related]
6. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Corvol JC; Bouzamondo A; Sirol M; Hulot JS; Sanchez P; Lechat P Arch Intern Med; 2003 Mar; 163(6):669-76. PubMed ID: 12639199 [TBL] [Abstract][Full Text] [Related]
8. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications. Rifkind BM Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999 [TBL] [Abstract][Full Text] [Related]
9. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program. Grundy SM; Cleeman JI; Rifkind BM; Kuller LH Arch Intern Med; 1999 Aug 9-23; 159(15):1670-8. PubMed ID: 10448768 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy. Hunninghake DB Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501 [TBL] [Abstract][Full Text] [Related]
11. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
12. The pharmacoeconomic benefits of cholesterol reduction. Gonzalez ER Am J Manag Care; 1998 Feb; 4(2):223-30. PubMed ID: 10178493 [TBL] [Abstract][Full Text] [Related]
14. Management of high serum cholesterol and related disorders in patients at risk for coronary heart disease. Grundy SM Am J Med; 1997 Feb; 102(2A):15-22. PubMed ID: 9217581 [TBL] [Abstract][Full Text] [Related]
15. Are we aggressive enough in lowering cholesterol? Waters DD Am J Cardiol; 2001 Aug; 88(4A):10F-5F. PubMed ID: 11520481 [TBL] [Abstract][Full Text] [Related]
16. Cholesterol: precursor to many lipid disorders. Jones PH Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815 [TBL] [Abstract][Full Text] [Related]
17. "The lower the better" in hypercholesterolemia therapy: a reliable clinical guideline? Jacobson TA Ann Intern Med; 2000 Oct; 133(7):549-54. PubMed ID: 11015169 [TBL] [Abstract][Full Text] [Related]
18. Choice of cholesterol-lowering drugs. Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674 [No Abstract] [Full Text] [Related]
19. Review of recent clinical trials of lipid lowering in coronary artery disease. Smith SC Am J Cardiol; 1997 Oct; 80(8B):10H-13H. PubMed ID: 9372993 [TBL] [Abstract][Full Text] [Related]
20. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study]. Ditschuneit HH; Dreyer M; Dammann HG; Ditschuneit H Med Klin (Munich); 1991 Mar; 86(3):142-8. PubMed ID: 1903497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]